产品详情
简单介绍：
Anti-C6orf165抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-C6orf165抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-C6orf165
Cat. Number:
Anti-C6orf165抗体KL-15228R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes
Anti-C6orf165抗体an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf165 gene product has been provisionally designated C6orf165 pending further characterization.
Also known as:
C6orf165; CF165_HUMAN;
Anti-C6orf165抗体Chromosome 6 open reading frame 165; dJ382I10.1; UPF0704 protein C6orf165.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf165.
●
Predicted Molecular Weight: 71kDa.
Storage:
Shipped at 4℃, Store at -20℃
Anti-C6orf165抗体(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-C6orf165抗体must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-C6orf165抗体must be determined by the end user.
kl352Mu01 *******调节转录肽(CART)多克隆抗体 Polyclonal Antibody to Cocaine And Amphetamine Regulated Transcript (CART)
kl352Mu02 *******调节转录肽(CART)多克隆抗体 Polyclonal Antibody to Cocaine And Amphetamine Regulated Transcript (CART)
kl352Ra01 *******调节转录肽(CART)多克隆抗体 Polyclonal Antibody to Cocaine And Amphetamine Regulated Transcript (CART)
kl355Mu02 甲状腺球蛋白(TG)多克隆抗体 Polyclonal Antibody to Thyroglobulin (TG)
kl362Mu01 尾加压素2(UST2)多克隆抗体 Polyclonal Antibody to Urotensin 2 (UST2)
kl362Mu02 尾加压素2(UST2)多克隆抗体 Polyclonal Antibody to Urotensin 2 (UST2)
kl370Mu02 β-血小板球蛋白(βTG)多克隆抗体 Polyclonal Antibody to Beta-Thromboglobulin (bTG)
kl371Mu02 10kDa干扰素γ诱导蛋白(IP10)多克隆抗体 Polyclonal Antibody to Interferon Gamma Induced Protein 10kDa (IP10)
kl372Mu02 凝溶胶蛋白(GS)多克隆抗体 Polyclonal Antibody to Gelsolin (GS)
kl373Mu02 结蛋白(Des)多克隆抗体 Polyclonal Antibody to Desmin (Des)
kl380Gu01 血管活性肠肽(VIP)多克隆抗体 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Mu02 血管活性肠肽(VIP)多克隆抗体 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl383Mu02 磷酸肌醇-3-激酶2α肽(PI3K2α)多克隆抗体 Polyclonal Antibody to Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a)
kl384Mu02 白介素23(IL23)多克隆抗体 Polyclonal Antibody to Interleukin 23 (IL23)
kl386Mu02 脂蛋白脂酶(LIPD)多克隆抗体 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl389Hu01 补体成分4a(C4a)多克隆抗体 Polyclonal Antibody to Complement Component 4a (C4a)
kl389Mu02 补体成分4a(C4a)多克隆抗体 Polyclonal Antibody to Complement Component 4a (C4a)
